Together, these findings indicate that scFv PD-L1 has anti-tumor activity in two glioma tumor models and Tu-2449 tumor model represents a previously undescribed glioma mouse model that responds to checkpoint inhibitors as a monotherapy. The gene discussed is CD274; the disease is glioma.